Endocyte Balance Sheet - Annual (NASDAQ:ECYT)

Add to My Stocks
$17.54 $0.43 (2.39%) ECYT stock closing price Sep 19, 2018 (Closing)

The Endocyte balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Endocyte stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Endocyte revenue Endocyte operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Endocyte balance sheet for 2017 shows cash on hand of $18.55M. The company has a debt to equity ratio of 0.

View latest 10 year balance sheet data to check Endocyte financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Marketable Securities78.91M106.97M158.16M79.53M70.43M141.84M66.73M-15.21M-
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets-1.99M1.26M1.26M3.69M3.29M1.67M3.17M--
Total Current Assets
Property Plant & Equipment7.36M8.45M7.75M7.47M6.62M5.3M3.15M3.17M2.97M-
Accumulated Depreciation5.18M5.25M4.35M3.5M2.78M2.13M2.04M2.31M2.05M-
Net Property Plant & Equipment
Investment & Advances---81.76M25.57M25.54M----
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable-1.38M1.26M1.23M5.43M3.64M2.12M2.83M1.78M-
Current Portion Long-Term Debt-------4.31M6.25M-
Current Portion Capital Leases----------
Accrued Expenses4.16M4.18M4.92M5.59M8.46M6.81M1.8M---
Income Taxes Payable----------
Other Current Liabilities----59.76M51.99M1.54M---
Total Current Liabilities
Deferred Taxes/Income-----51.99M----
Convertible Debt----------
Long-Term Debt------12.83M20.01M2.71M-
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest-------89.79M89.79M-
Preferred Stock----------
Common Stock Net-------1.15M1.91M-
Capital Surplus404.45M390.76M381.11M373.57M262.06M255.35M251.94M---
Retained Earnings-308.95M-253.62M-209.73M-168.46M-173.92M-155.89M-138.6M-98.06M-77.97M-
Treasury Stock----------
Other Liabilities-0.06M-0.04M-0.07M-0.14M---0.01M---
Shareholders Equity95.48M137.14M171.34M205M88.22M99.57M113.37M-96.91M-76.05M-
Total Liabilities & Shareholders Equity100.76M143.49M178.38M212.8M162.85M214.07M131.67M21.21M25.26M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Endocyte stock price, and Endocyte historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Endocyte PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Endocyte owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for ECYT stock as of 2017 is $100.76M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. ECYT stock had total liabilities of $5.27M for the year 2017.

Endocyte Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio